Trials / Completed
CompletedNCT00483860
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
A Phase I Study of Oral Topotecan in Subjects With Cancer and Impaired Renal Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effect of renal impairment and prior platinum-based chemotherapy on the safety and blood levels of topotecan administered orally
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topotecan | once a day |
Timeline
- Start date
- 2007-06-20
- Primary completion
- 2012-02-06
- Completion
- 2012-02-06
- First posted
- 2007-06-07
- Last updated
- 2017-11-13
Locations
6 sites across 3 countries: United States, Netherlands, South Korea
Source: ClinicalTrials.gov record NCT00483860. Inclusion in this directory is not an endorsement.